drugset / Trial / NCT06235281
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
Phase 0
Suspended
20 enrolled
H. Lee Moffitt Cancer Center and Research Institute
Kyowa Hakko Kirin Pharma, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open label, single arm, single-center, pilot study of concurrent phototherapy and POTELIGEO (mogamulizumab-kpkc) in early-stage mycosis fungoides.
Timeline
- Start
- 2024-01-18
- Primary completion
- 2026-09-01
- Completion
- 2029-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mogamulizumab | Monoclonal antibody | — | — |